JAMES WHEELER: Open Payments
NPI 1275537094 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,155 in 64 payments from 20 companies in 2025. Trend: 2023 $1,207 · 2024 $1,217 · 2025 $1,155
Food & beverage: $1,155
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $171 |
| ABBVIE INC. | 9 | $165 |
| PFIZER INC. | 10 | $144 |
| Novartis Pharmaceuticals Corporation | 4 | $95 |
| Lilly USA, LLC | 5 | $83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $67 |
| Otsuka America Pharmaceutical, Inc. | 4 | $65 |
| Phathom Pharmaceuticals, Inc. | 3 | $51 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| Amgen Inc. | 3 | $47 |
Products named: Wegovy, NURTEC ODT, LEQVIO, VRAYLAR, UBRELVY, REXULTI, VOQUEZNA, TRELEGY ELLIPTA.
Industry payments across KY — which companies pay providers there.
